You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


Novel Therapies for Multiple Myeloma: Highlights for the Oncology Nurse

  • Authors: Sandra E. Kurtin, PhD, ANP-C, AOCN
  • CE Released: 10/22/2020
  • Valid for credit through: 10/22/2021
Start Activity

Target Audience and Goal Statement

This activity is intended for oncology nurses and other healthcare providers involved in the care of patients with MM.

The goal of this activity is to improve the knowledge of oncology nurses about novel and emerging therapies used to treat multiple relapsed/refractory (R/R) multiple myeloma (MM) and to improve their skills educating patients about participation in clinical trials.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Risk factors for developing R/R MM
    • Potential adverse effects of novel therapies for R/R MM
  • Have greater competence related to
    • Discussing clinical trial participation with patients with R/R MM
  • Demonstrate greater confidence in their ability to
    • Provide education about novel therapies to patients with R/R MM


As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


  • Sandra E. Kurtin, PhD, ANP-C, AOCN

    Director, Advanced Practice
    Assistant Professor of Clinical Medicine
    Assistant Professor of Nursing
    The University of Arizona Cancer Center
    Tucson, Arizona


    Disclosure: Sandra E. Kurtin, PhD, ANP-C, AOCN, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Abbvie; Amgen; AstraZeneca; Genentech; Incyte; Pharmacyclics; Takeda
    Served as a speaker or a member of a speakers bureau for: Abbvie; Amgen; AstraZeneca; Genentech; Incyte; Pharmacyclics; Takeda


  • Sara Fagerlie, PhD, CHCP

    Medical Education Director, WebMD Global, LLC


    Disclosure: Sara Fagerlie, PhD, CHCP, has disclosed no relevant financial relationships.

CE Reviewer/Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC


    Disclosure: Stephanie Corder, ND, RN, CHCP, has disclosed no relevant financial relationships.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Nurses

  • Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


Novel Therapies for Multiple Myeloma: Highlights for the Oncology Nurse

Authors: Sandra E. Kurtin, PhD, ANP-C, AOCNFaculty and Disclosures

CE Released: 10/22/2020

Valid for credit through: 10/22/2021


A Powerpoint version of the slides from this presentation
is available for use as a professional resource from Medscape Education.

  • Print